05.15.26 -- Record‑Setting Drugs, Smarter Trials, And What's Next for Pharma

Last year set a record for new active substances with 105 debuts, beating 2021’s 97. In 2025, 97 new drugs launched, surpassing the prior record of 84.

As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's?

Awareness campaigns and site expansion still miss key patients. Community‑rooted recruitment is emerging as the way to build trust, access, and participation where people live.

High screen failure rates and patient dropout often stem from preventable imaging errors. Learn how proactive quality control and patient-centric logistics secure critical retinal trial data.

Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.

As the digital backbone for real-time production control and data integrity, see how a manufacturing execution system (MES) orchestrates production processes from start to finish.